IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study (IMPULSION)
研究概览
详细说明
Physicians from 20 hospitals and 40 health centres (primary health care settings) were trained to implement guidelines in treating arterial hypertension.
There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form (by ticking pre-specified boxes) about the baseline status of the patients and will have to report the measures they took to improve awareness, treatment, and effective control of arterial hypertension. After a six month effort, physicians will have to complete the same form at study completion. Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target, and will minimise the target organ damage. The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk (as evaluated by a risk engine, i.e. PROCAM) at study completion with that of baseline.
研究类型
注册 (预期的)
联系人和位置
学习地点
-
-
-
Thessaloniki、希腊、55132
- Hellenic Atherosclerosis Society
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Arterial hypertension as defined by the JNC 7 report
Exclusion Criteria:
- Pregnancy
- Lactation
- Malignancies with small life expectancy
- Unwillingness to participate
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Efficacy in arterial hypertension control
大体时间:6 months
|
6 months
|
|
Efficacy in reducing estimated risk of coronary heart disease
大体时间:6 months
|
6 months
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Cost effectiveness of arterial hypertension control
大体时间:6 months
|
6 months
|
|
Differences between primary and secondary health care settings as well as teaching hospitals
大体时间:6 months
|
6 months
|
合作者和调查者
调查人员
- 研究主任:Athyros G Athyros, MD、Clinical Trials Chair of Hellenic Atherosclerosis Society
出版物和有用的链接
一般刊物
- Karagiannis A, Athyros VG, Papageorgiou A, Tziomalos K, Elisaf M. Should atenolol still be recommended as first-line therapy for primary hypertension? Hellenic J Cardiol. 2006 Sep-Oct;47(5):298-307. No abstract available.
- Karagiannis A, Hatzitolios AI, Athyros VG, Deligianni K, Charalambous C, Papathanakis C, Theodosiou G, Drakidis T, Chatzikaloudi V, Kamilali C, Matsiras S, Matziris A, Savopoulos C, Baltatzi M, Rudolf J, Tziomalos K, Mikhailidis DP. Implementation of guidelines for the management of arterial hypertension. The impulsion study. Open Cardiovasc Med J. 2009 May 5;3:26-34. doi: 10.2174/1874192400903010026.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- HAS-02-231206
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.